Fig. 1 · Structure
Documents & Downloads
Flurocitabine hydrochloride
Antitumor Agent
Flurocitabine hydrochloride is an antitumor agent that exerts its effects by undergoing hydrolysis in vivo to yield two active metabolites: arabinosyl-fluorocytosine (ara-FC) and arabinosyl-fluorouracil (ara-FU). These metabolites are involved in disrupting nucleic acid synthesis, making Flurocitabine hydrochloride a valuable tool in cancer research. Its ability to target tumor growth positions it as a significant compound for studies focused on chemotherapy and the development of novel anticancer therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 40505-45-1 |
| Applications | Antitumor Agent |
| Formula | C9H11ClFN3O4 |
| Molecular Weight | 279.65 |
| Synonyms | 5-Fluorocyclocytidine hydrochloride; 5'-Fluorocyclocytidine hydrochloride |
| SMILES | O[C@H]1[C@@]2([H])[C@](O[C@@H]1CO)([H])N3C(O2)=NC(C(F)=C3)=N.Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.